Nov 11 (Reuters) – * SHANTON PHARMA RECEIVES EMA AND FDA PEDIATRIC STUDY WAIVERS FOR SAP-001 IN HYPERURICEMIA Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: BILLIE JEAN KING AND MORE ATTEND THE PREMIERE OF 'GIVE ME THE BALL!'…
By Stephanie Kelly LONDON, Nov 11 (Reuters) - Oil prices rose about 1% on Wednesday…
Nov 11 (Reuters) - AI agent developer Rox said on Wednesday it had raised $100…
Nov 11 (Reuters) - RioCan Real Estate Investment Trust : * RIOCAN REAL ESTATE INVESTMENT…
VIDEO SHOWS: INTERVIEW WITH MOTOGP DEPUTY CEO CARLOS EZPELETA / STILL IMAGES OF QATAR GRAND…
MADRID, Nov 11 (Reuters) - Spanish lender Sabadell has been fined €16.5 million ($17.7 million)…